China SXT Pharmaceuticals, Inc.
SXTCDrugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
1 upcoming, 1 past
Stock Offering — $12 Million
China SXT Pharmaceuticals announced a $12 million registered direct offering of 8,000,000 Class A ordinary shares to institutional investors.
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is China SXT Pharmaceuticals, Inc.'s next FDA catalyst?→
China SXT Pharmaceuticals, Inc.'s (SXTC) next tracked catalyst is a Earnings expected October 7, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track SXTC biotech catalysts?→
Add SXTC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow China SXT Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.